Skip to main content
Erschienen in:

30.01.2022

Acromegaly and pregnancy: a systematic review and meta-analysis

verfasst von: Diego Barata Bandeira, Thaina Oliveira Felicio Olivatti, Fernanda Bolfi, Cesar Luiz Boguszewski, Vania dos Santos Nunes-Nogueira

Erschienen in: Pituitary | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the association between acromegaly and pregnancy in terms of disease activity, maternal and fetal outcomes.

Methods

This systematic review was conducted according to the Joanna Briggs Institute methodology for systematic reviews of etiology and risk. We focused on observational studies that included pregnant women with acromegaly. The outcomes were acromegaly activity, preterm birth, gestational diabetes, hypertension, eclampsia/preeclampsia, miscarriage, perinatal mortality, low birthweight, small for gestational age, and congenital malformations. Embase, Medline, LILACS, and CENTRAL were our source databases. To perform proportional meta-analyses, we used Stata Statistical Software 17.

Results

Nineteen studies were included encompassing a total of 273 pregnancies in 211 women with acromegaly. The overall frequency of control of acromegaly during pregnancy was 62%, and of tumor growth was 9%. No fetal or maternal deaths were reported. The overall frequency of worsening of previous diabetes or development of gestational diabetes was 9%, and of previous hypertension or preeclampsia/eclampsia was 6%. The overall frequency of premature labor was 9% [from 17 studies of 263 pregnancies; 95% confidence interval (CI), 5–13%]; of spontaneous miscarriage was 4% (from 19 studies of 273 pregnancies; 95% CI, 2–11%); of small for gestational age was 5% (from 15 studies of 216 newborns; 95% CI, 3–9%); and of congenital malformations was 1% (from 18 studies of 240 newborns; 95% CI, 0–7%).

Conclusion

Pregnancy in women with acromegaly is frequently associated with disease control and is safe in relation to fetal and maternal outcomes, as in women without acromegaly.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Grynberg M, Salenave S, Young J, Chanson P (2010) Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab 95(10):4518–4525CrossRefPubMed Grynberg M, Salenave S, Young J, Chanson P (2010) Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab 95(10):4518–4525CrossRefPubMed
2.
Zurück zum Zitat Caron P, Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet-Rudelli C, Chanson P (2010) Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 95(10):4680–4687CrossRefPubMed Caron P, Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet-Rudelli C, Chanson P (2010) Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 95(10):4680–4687CrossRefPubMed
3.
Zurück zum Zitat Caron P (2011) Acromegaly and pregnancy. Ann Endocrinol 72(4):282–286CrossRef Caron P (2011) Acromegaly and pregnancy. Ann Endocrinol 72(4):282–286CrossRef
4.
Zurück zum Zitat Goluboff LG, Ezrin C (1969) Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. J Clin Endocrinol Metab 29(12):1533–1538CrossRefPubMed Goluboff LG, Ezrin C (1969) Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. J Clin Endocrinol Metab 29(12):1533–1538CrossRefPubMed
5.
Zurück zum Zitat Montini M, Pagani G, Gianola D, Pagani MD, Piolini R, Camboni MG (1990) Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201–995 and bromocriptine. J Endocrinol Invest 13(2):193CrossRefPubMed Montini M, Pagani G, Gianola D, Pagani MD, Piolini R, Camboni MG (1990) Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201–995 and bromocriptine. J Endocrinol Invest 13(2):193CrossRefPubMed
6.
Zurück zum Zitat Hannon AM, O’Shea T, Thompson CA, Hannon MJ, Dineen R, Khattak A, Gibney J, O’Halloran DJ, Hunter S, Thompson CJ, Sherlock M (2019) Pregnancy in acromegaly is safe and is associated with improvements in IGF-1 concentrations. Eur J Endocrinol 180(4):K21–K29CrossRefPubMed Hannon AM, O’Shea T, Thompson CA, Hannon MJ, Dineen R, Khattak A, Gibney J, O’Halloran DJ, Hunter S, Thompson CJ, Sherlock M (2019) Pregnancy in acromegaly is safe and is associated with improvements in IGF-1 concentrations. Eur J Endocrinol 180(4):K21–K29CrossRefPubMed
7.
Zurück zum Zitat Dias M, Boguszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JG, Abucham J (2014) Acromegaly and pregnancy: a prospective study. Eur J Endocrinol 170(2):301–310CrossRefPubMed Dias M, Boguszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JG, Abucham J (2014) Acromegaly and pregnancy: a prospective study. Eur J Endocrinol 170(2):301–310CrossRefPubMed
8.
Zurück zum Zitat Jallad RS, Shimon I, Fraenkel M, Medvedovsky V, Akirov A, Duarte FH, Bronstein MD (2018) Outcome of pregnancies in a large cohort of women with acromegaly. Clin Endocrinol (Oxf) 88(6):896–907CrossRef Jallad RS, Shimon I, Fraenkel M, Medvedovsky V, Akirov A, Duarte FH, Bronstein MD (2018) Outcome of pregnancies in a large cohort of women with acromegaly. Clin Endocrinol (Oxf) 88(6):896–907CrossRef
9.
Zurück zum Zitat Chanson P, Vialon M, Caron P (2019) An update on clinical care for pregnant women with acromegaly. Expert Rev Endocrinol Metab 14(2):85–96CrossRefPubMed Chanson P, Vialon M, Caron P (2019) An update on clinical care for pregnant women with acromegaly. Expert Rev Endocrinol Metab 14(2):85–96CrossRefPubMed
10.
Zurück zum Zitat Moola SMZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R et al (2017) Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z (eds) Joanna Briggs Institute Reviewer’s Manual. The Joanna Briggs Institute, Adelaide Moola SMZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R et al (2017) Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z (eds) Joanna Briggs Institute Reviewer’s Manual. The Joanna Briggs Institute, Adelaide
11.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151(4):W65-94CrossRefPubMed Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151(4):W65-94CrossRefPubMed
12.
Zurück zum Zitat Bandeira DB, Olivatti TOF, Bolfi F, Boguszewski CL, dos Santos Nunes-Nogueira V (2020) Acromegaly and pregnancy: a systematic review protocol. Asian J Adv Res Rep 14(4):5 Bandeira DB, Olivatti TOF, Bolfi F, Boguszewski CL, dos Santos Nunes-Nogueira V (2020) Acromegaly and pregnancy: a systematic review protocol. Asian J Adv Res Rep 14(4):5
13.
Zurück zum Zitat Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine S (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951CrossRefPubMed Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine S (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951CrossRefPubMed
15.
Zurück zum Zitat Munn ZBT, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E (2020) Methodological quality of case series studies. JBI Evid Synth 18(10):2127–2133PubMed Munn ZBT, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E (2020) Methodological quality of case series studies. JBI Evid Synth 18(10):2127–2133PubMed
16.
Zurück zum Zitat Riley RD, Higgins JP, Deeks JJ (2011) Interpretation of random effects meta-analyses. BMJ (Clin Res Ed) 342:d549CrossRef Riley RD, Higgins JP, Deeks JJ (2011) Interpretation of random effects meta-analyses. BMJ (Clin Res Ed) 342:d549CrossRef
17.
Zurück zum Zitat Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64(4):401–406CrossRefPubMed Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64(4):401–406CrossRefPubMed
18.
Zurück zum Zitat Assal A, Malcolm J, Lochnan H, Keely E (2016) Preconception counselling for women with acromegaly: more questions than answers. Obstet Med 9(1):9–14CrossRefPubMed Assal A, Malcolm J, Lochnan H, Keely E (2016) Preconception counselling for women with acromegaly: more questions than answers. Obstet Med 9(1):9–14CrossRefPubMed
19.
Zurück zum Zitat Atmaca A, Dagdelen S, Erbas T (2006) Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp Clin Endocrinol Diabetes 114(3):135–139CrossRefPubMed Atmaca A, Dagdelen S, Erbas T (2006) Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp Clin Endocrinol Diabetes 114(3):135–139CrossRefPubMed
20.
Zurück zum Zitat Cheng V, Faiman C, Kennedy L, Khoury F, Hatipoglu B, Weil R, Hamrahian A (2012) Pregnancy and acromegaly: a review. Pituitary 15(1):59–63CrossRefPubMed Cheng V, Faiman C, Kennedy L, Khoury F, Hatipoglu B, Weil R, Hamrahian A (2012) Pregnancy and acromegaly: a review. Pituitary 15(1):59–63CrossRefPubMed
21.
Zurück zum Zitat Cozzi R, Attanasio R, Barausse M (2006) Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol 155(2):279–284CrossRefPubMed Cozzi R, Attanasio R, Barausse M (2006) Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol 155(2):279–284CrossRefPubMed
22.
Zurück zum Zitat Dias M, Bouszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JGH, Abucham J (2014) Acromegaly and pregnancy: a prospective study. Eur J Endocrinol 170(2):301–310CrossRefPubMed Dias M, Bouszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JGH, Abucham J (2014) Acromegaly and pregnancy: a prospective study. Eur J Endocrinol 170(2):301–310CrossRefPubMed
23.
Zurück zum Zitat Dogansen SC, Tanrikulu S, Yalin GY, Yarman S (2018) Female gonadal functions and ovarian reserve in patients with acromegaly: experience from a single tertiary center. Endocrine 60(1):167–174CrossRefPubMed Dogansen SC, Tanrikulu S, Yalin GY, Yarman S (2018) Female gonadal functions and ovarian reserve in patients with acromegaly: experience from a single tertiary center. Endocrine 60(1):167–174CrossRefPubMed
24.
Zurück zum Zitat Guitelman MA, Tkatch J, Rosmino J, Pingel J (2018) Acromegaly: a single center retrospective study of 11 pregnancies. Endocr Rev 39(2) Guitelman MA, Tkatch J, Rosmino J, Pingel J (2018) Acromegaly: a single center retrospective study of 11 pregnancies. Endocr Rev 39(2)
25.
Zurück zum Zitat Haliloglu O, Dogangun B, Ozcabi B, Kural HU, Keskin FE, Ozkaya HM, Pamukcu FC, Bektas E, Poyraz BC, Buber H, Evliyaoglu O, Kadioglu P (2016) General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers. Pituitary 19(4):391–398CrossRefPubMed Haliloglu O, Dogangun B, Ozcabi B, Kural HU, Keskin FE, Ozkaya HM, Pamukcu FC, Bektas E, Poyraz BC, Buber H, Evliyaoglu O, Kadioglu P (2016) General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers. Pituitary 19(4):391–398CrossRefPubMed
26.
Zurück zum Zitat Herman-Bonert V, Seliverstov M, Melmed S (1998) Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83(3):727–731PubMed Herman-Bonert V, Seliverstov M, Melmed S (1998) Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83(3):727–731PubMed
27.
Zurück zum Zitat Karaca Z, Yarman S, Ozbas I, Kadioglu P, Akturk M, Kilicli F, Dokmetas HS, Colak R, Atmaca H, Canturk Z, Altuntas Y, Ozbey N, Hatipoglu N, Tanriverdi F, Unluhizarci K, Kelestimur F (2018) How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey. J Endocrinol Invest 41(1):129–141CrossRefPubMed Karaca Z, Yarman S, Ozbas I, Kadioglu P, Akturk M, Kilicli F, Dokmetas HS, Colak R, Atmaca H, Canturk Z, Altuntas Y, Ozbey N, Hatipoglu N, Tanriverdi F, Unluhizarci K, Kelestimur F (2018) How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey. J Endocrinol Invest 41(1):129–141CrossRefPubMed
28.
Zurück zum Zitat Guarda FJ, Gong W, Ghajar A, Guitelman M, Nachtigall LB (2020) Preconception use of pegvisomant alone or as combination therapy for acromegaly: a case series and review of the literature. Pituitary 23(5):498–506CrossRefPubMed Guarda FJ, Gong W, Ghajar A, Guitelman M, Nachtigall LB (2020) Preconception use of pegvisomant alone or as combination therapy for acromegaly: a case series and review of the literature. Pituitary 23(5):498–506CrossRefPubMed
29.
Zurück zum Zitat Önder E, Aydın Y, Soysal T, Tuna M, Güngör A (2017) Acromegaly and pregnancy: five new cases. Akromegali ve gebelik: beş yeni vaka. Turk J Endocrinol Metab 21(4):136–139CrossRef Önder E, Aydın Y, Soysal T, Tuna M, Güngör A (2017) Acromegaly and pregnancy: five new cases. Akromegali ve gebelik: beş yeni vaka. Turk J Endocrinol Metab 21(4):136–139CrossRef
30.
Zurück zum Zitat Persechini ML, Gennero I, Grunenwald S, Vezzosi D, Bennet A, Caron P (2014) Acromegaly and pregnancy: report of six new cases. J Gynecol Obstet Biol Reprod 43(9):704–712CrossRef Persechini ML, Gennero I, Grunenwald S, Vezzosi D, Bennet A, Caron P (2014) Acromegaly and pregnancy: report of six new cases. J Gynecol Obstet Biol Reprod 43(9):704–712CrossRef
31.
Zurück zum Zitat Van Der Lely AJ, Gomez R, Heissler JF, Åkerblad AC, Jönsson P, Camacho-Hübner C, Kołtowska-Häggström M (2014) Pregnancy in acromegaly patients treated with pegvisomant. Growth Hormon IGF Res 24:S40CrossRef Van Der Lely AJ, Gomez R, Heissler JF, Åkerblad AC, Jönsson P, Camacho-Hübner C, Kołtowska-Häggström M (2014) Pregnancy in acromegaly patients treated with pegvisomant. Growth Hormon IGF Res 24:S40CrossRef
32.
Zurück zum Zitat Vialon M, Grunenwald S, Mouly C, Vezzosi D, Bennet A, Gourdy P, Caron PJ (2019) Gestational diabetes and acromegaly: single-centre experience of 14 pregnancies. Clin Endocrinol (Oxf) 91(6):805–809CrossRef Vialon M, Grunenwald S, Mouly C, Vezzosi D, Bennet A, Gourdy P, Caron PJ (2019) Gestational diabetes and acromegaly: single-centre experience of 14 pregnancies. Clin Endocrinol (Oxf) 91(6):805–809CrossRef
33.
Zurück zum Zitat Colao A, Merola B, Ferone D, Lombardi G (1997) Acromegaly. J Clin Endocrinol Metab 82(9):2777–2781CrossRefPubMed Colao A, Merola B, Ferone D, Lombardi G (1997) Acromegaly. J Clin Endocrinol Metab 82(9):2777–2781CrossRefPubMed
34.
Zurück zum Zitat Andreeva M, Tomova A, Shterev A (1990) Acromegaly and pregnancy. Vutr Boles 29(1):94–99PubMed Andreeva M, Tomova A, Shterev A (1990) Acromegaly and pregnancy. Vutr Boles 29(1):94–99PubMed
35.
Zurück zum Zitat Rees K, Lambert K, Seed P, Dhanjal MK, Knight M, McCance DR, Williamson C (2016) Pituitary tumours in pregnancy: a 3-year prospective UK national cohort study. BJOG Int J Obstet Gynaecol 123:19 Rees K, Lambert K, Seed P, Dhanjal MK, Knight M, McCance DR, Williamson C (2016) Pituitary tumours in pregnancy: a 3-year prospective UK national cohort study. BJOG Int J Obstet Gynaecol 123:19
36.
Zurück zum Zitat Lambert K, Rees K, Seed PT, Dhanjal MK, Knight M, McCance DR, Williamson C (2017) Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes. Obstet Gynecol 129(1):185–194CrossRefPubMed Lambert K, Rees K, Seed PT, Dhanjal MK, Knight M, McCance DR, Williamson C (2017) Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes. Obstet Gynecol 129(1):185–194CrossRefPubMed
37.
Zurück zum Zitat Muhammad A, Neggers SJ, van der Lely AJ (2017) Pregnancy and acromegaly. Pituitary 20(1):179–184CrossRefPubMed Muhammad A, Neggers SJ, van der Lely AJ (2017) Pregnancy and acromegaly. Pituitary 20(1):179–184CrossRefPubMed
38.
Zurück zum Zitat Abucham J, Bronstein MD, Dias ML (2017) Acromegaly and pregnancy: a contemporary review. Eur J Endocrinol 177(1):R1–R12CrossRefPubMed Abucham J, Bronstein MD, Dias ML (2017) Acromegaly and pregnancy: a contemporary review. Eur J Endocrinol 177(1):R1–R12CrossRefPubMed
39.
Zurück zum Zitat Marques JVO, Boguszewski CL (2020) Fertility issues in aggressive pituitary tumors. Rev Endocr Metab Disord 21(2):225–233CrossRefPubMed Marques JVO, Boguszewski CL (2020) Fertility issues in aggressive pituitary tumors. Rev Endocr Metab Disord 21(2):225–233CrossRefPubMed
40.
Zurück zum Zitat Davenport ML, Clemmons DR, Miles MV, Camacho-Hubner C, D’Ercole AJ, Underwood LE (1990) Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology 127(3):1278–1286CrossRefPubMed Davenport ML, Clemmons DR, Miles MV, Camacho-Hubner C, D’Ercole AJ, Underwood LE (1990) Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology 127(3):1278–1286CrossRefPubMed
41.
Zurück zum Zitat Han VK, Carter AM (2000) Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21(4):289–305CrossRefPubMed Han VK, Carter AM (2000) Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21(4):289–305CrossRefPubMed
42.
Zurück zum Zitat Nayak NR, Giudice LC (2003) Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta 24(4):281–296CrossRefPubMed Nayak NR, Giudice LC (2003) Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta 24(4):281–296CrossRefPubMed
43.
Zurück zum Zitat Wiesli P, Zwimpfer C, Zapf J, Schmid C (2006) Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Acta Obstet Gynecol Scand 85(8):900–905CrossRefPubMed Wiesli P, Zwimpfer C, Zapf J, Schmid C (2006) Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Acta Obstet Gynecol Scand 85(8):900–905CrossRefPubMed
44.
Zurück zum Zitat Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25(5):693–721CrossRefPubMed Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25(5):693–721CrossRefPubMed
45.
Zurück zum Zitat Alexopoulou O, Bex M, Kamenicky P, Mvoula AB, Chanson P, Maiter D (2014) Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. Pituitary 17(1):81–89CrossRefPubMed Alexopoulou O, Bex M, Kamenicky P, Mvoula AB, Chanson P, Maiter D (2014) Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. Pituitary 17(1):81–89CrossRefPubMed
46.
Zurück zum Zitat Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M, Auriemma R, Diallo AM, Hulting AL, Ferone D, Hana V Jr, Filipponi S, Sievers C, Nogueira C, Fajardo-Montanana C, Carvalho D, Hana V, Stalla GK, Jaffrain-Rea ML, Delemer B, Colao A, Brue T, Neggers S, Zacharieva S, Chanson P, Beckers A (2017) Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database. Endocr Relat Cancer 24(10):505–518CrossRefPubMedPubMedCentral Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M, Auriemma R, Diallo AM, Hulting AL, Ferone D, Hana V Jr, Filipponi S, Sievers C, Nogueira C, Fajardo-Montanana C, Carvalho D, Hana V, Stalla GK, Jaffrain-Rea ML, Delemer B, Colao A, Brue T, Neggers S, Zacharieva S, Chanson P, Beckers A (2017) Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database. Endocr Relat Cancer 24(10):505–518CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Federation ID (2019) IDF diabetes atlas ninth. IDF, Dunia Federation ID (2019) IDF diabetes atlas ninth. IDF, Dunia
48.
Zurück zum Zitat Vila G, Luger A, van der Lely AJ, Neggers S, Webb SM, Biller BMK, Valluri S, Hey-Hadavi J (2020) Hypertension in acromegaly in relationship to biochemical control and mortality: global ACROSTUDY outcomes. Front Endocrinol (Lausanne) 11:577173CrossRef Vila G, Luger A, van der Lely AJ, Neggers S, Webb SM, Biller BMK, Valluri S, Hey-Hadavi J (2020) Hypertension in acromegaly in relationship to biochemical control and mortality: global ACROSTUDY outcomes. Front Endocrinol (Lausanne) 11:577173CrossRef
49.
Zurück zum Zitat Butwick AJ, Druzin ML, Shaw GM, Guo N (2020) Evaluation of US State-level variation in hypertensive disorders of pregnancy. JAMA Netw Open 3(10):e2018741CrossRefPubMedPubMedCentral Butwick AJ, Druzin ML, Shaw GM, Guo N (2020) Evaluation of US State-level variation in hypertensive disorders of pregnancy. JAMA Netw Open 3(10):e2018741CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Berhe AK, Kassa GM, Fekadu GA, Muche AA (2018) Prevalence of hypertensive disorders of pregnancy in Ethiopia: a systemic review and meta-analysis. BMC Pregnancy Childbirth 18(1):34CrossRefPubMedPubMedCentral Berhe AK, Kassa GM, Fekadu GA, Muche AA (2018) Prevalence of hypertensive disorders of pregnancy in Ethiopia: a systemic review and meta-analysis. BMC Pregnancy Childbirth 18(1):34CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Wang X, Chen C, Wang L, Chen D, Guang W, French J (2003) Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril 79(3):577–584CrossRefPubMed Wang X, Chen C, Wang L, Chen D, Guang W, French J (2003) Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril 79(3):577–584CrossRefPubMed
52.
Zurück zum Zitat Walani SR (2020) Global burden of preterm birth. Int J Gynaecol Obstet Off Organ Int Federation Gynaecol Obstet 150(1):31–33CrossRef Walani SR (2020) Global burden of preterm birth. Int J Gynaecol Obstet Off Organ Int Federation Gynaecol Obstet 150(1):31–33CrossRef
53.
Zurück zum Zitat Black RE (2015) Global prevalence of small for gestational age births. Nestle Nutr Inst Workshop Ser 81:1–7CrossRefPubMed Black RE (2015) Global prevalence of small for gestational age births. Nestle Nutr Inst Workshop Ser 81:1–7CrossRefPubMed
54.
Zurück zum Zitat Ruiz M, Goldblatt P, Morrison J, Kukla L, Svancara J, Riitta-Jarvelin M, Taanila A, Saurel-Cubizolles MJ, Lioret S, Bakoula C, Veltsista A, Porta D, Forastiere F, van Eijsden M, Vrijkotte TG, Eggesbo M, White RA, Barros H, Correia S, Vrijheid M, Torrent M, Rebagliato M, Larranaga I, Ludvigsson J, Olsen Faresjo A, Hryhorczuk D, Antipkin Y, Marmot M, Pikhart H (2015) Mother’s education and the risk of preterm and small for gestational age birth: a DRIVERS meta-analysis of 12 European cohorts. J Epidemiol Community Health 69(9):826–833CrossRefPubMed Ruiz M, Goldblatt P, Morrison J, Kukla L, Svancara J, Riitta-Jarvelin M, Taanila A, Saurel-Cubizolles MJ, Lioret S, Bakoula C, Veltsista A, Porta D, Forastiere F, van Eijsden M, Vrijkotte TG, Eggesbo M, White RA, Barros H, Correia S, Vrijheid M, Torrent M, Rebagliato M, Larranaga I, Ludvigsson J, Olsen Faresjo A, Hryhorczuk D, Antipkin Y, Marmot M, Pikhart H (2015) Mother’s education and the risk of preterm and small for gestational age birth: a DRIVERS meta-analysis of 12 European cohorts. J Epidemiol Community Health 69(9):826–833CrossRefPubMed
55.
Zurück zum Zitat Dolk H, Loane M, Garne E (2010) The prevalence of congenital anomalies in Europe. Adv Exp Med Biol 686:349–364CrossRefPubMed Dolk H, Loane M, Garne E (2010) The prevalence of congenital anomalies in Europe. Adv Exp Med Biol 686:349–364CrossRefPubMed
Metadaten
Titel
Acromegaly and pregnancy: a systematic review and meta-analysis
verfasst von
Diego Barata Bandeira
Thaina Oliveira Felicio Olivatti
Fernanda Bolfi
Cesar Luiz Boguszewski
Vania dos Santos Nunes-Nogueira
Publikationsdatum
30.01.2022
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 3/2022
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-022-01208-0

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Metastasiertes CRC: besser Checkpointhemmer im Doppelpack!

Die Kombination von Nivolumab plus Ipilimumab ist beim metastasierten Kolorektalkarzinom mit MSI-H- oder dMMR klar im Vorteil gegenüber einer Nivolumab-Monotherapie: Das Progressionsrisiko war damit in einer Phase-3-Studie um 38% reduziert.

Riesenzellarteriitis: bilaterale Biopsie der Temporalarterien von Vorteil

Die Riesenzellarteriitis (RZA) erfordert eine rasche und präzise Diagnose, da innerhalb weniger Tage ein schwerer, irreversibler Sehverlust drohen kann. In diesem Zusammenhang scheint die bilaterale Biopsie der Temporalarterien (TAB) der unilateralen überlegen zu sein.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.